期刊文献+

Gli-1信号通路对TGF-β1诱导的人胃癌细胞上皮间质转化和侵袭的影响 被引量:1

Role of Gli-1 in TGF-β1 induced epithelial-mesenchymal transition and invasion in gastric cancer
下载PDF
导出
摘要 目的:探讨核转录因子神经胶质瘤关联癌基因同源物1(glioma associated oncogene homolog 1,Gli-1)对转化生长因子-β1(transforming growth factor-β1,TGF-β1)诱导的人胃癌SGC-7901细胞发生上皮间质转化(epithelial-mesenchymal transition,EMT)的作用机制。方法:体外采用10 ng/ml TGF-β1对胃癌SGC-7901细胞进行处理,使用倒置显微镜观察细胞形态变化,RT-PCR和Western blot检测EMT上皮表型蛋白E-cadherin和间质表型蛋白Vimentin的表达水平; Transwell细胞侵袭实验检测细胞侵袭能力变化,检测TGF-β1对SGC-7901细胞发生EMT的影响;同时采用RT-PCR和Western blot检测Gli-1的mRNA和蛋白表达水平。随后进一步采用Gli-1基因特异性阻断剂GANT 61阻断Gli-1表达,并使用TGF-β1(10 ng/ml)对SGC-7901细胞进行处理,RT-PCR和Western blot检测Gli-1、E-cadherin和Vimentin mRNA及其蛋白表达水平的改变,并使用Transwell细胞侵袭实验检测阻断Gli-1对SGC-7901细胞侵袭能力的影响。结果:TGF-β1可以诱导人胃癌SGC-7901细胞发生上皮间质转化并促进细胞侵袭。TGF-β1可以在mRNA和蛋白水平下调上皮表型蛋白E-cadherin的表达、提高Gli-1和间质表型蛋白Vimentin的表达。TGF-β1可以明显提高SGC-7901细胞侵袭,而阻断Gli-1后可以抑制TGF-β1诱导的人胃癌SGC-7901细胞上皮间质转化和细胞侵袭。结论:胃癌SGC-7901细胞中Gli-1可能参与TGF-β1介导的EMT的发生,Gli-1可能作为胃癌基因治疗中的有效靶点发挥作用。 Objective: To investigate the role of Gli-1 in TGF-β1 induced epithelial-mesenchymal transition( EMT) and invasion in gastric cancer cell line SGC-7901. Methods: Cultured SGC-7901 cells were treated with 10 ng/ml TGF-β1 for 24 h. The morphological changes were observed under phase-contrast microscopy. The mRNA and protein expression levels of Gli-1,EMT relative marker E-cadherin and Vimentin were detected by RT-PCR and Western blot. The effect of TGF-β1 on invasion ability of SGC-7901 cells were detected with Transwell method. Secondly,after co-treating with 10 ng/ml TGF-β1 and 10 μm GANT 61,RT-PCR and Western blot were used to check the mRNA and protein expression of Gli-1,E-cadherin and Vimentin. Transwell invasion assay was performed again to monitor cell invasion potentiality. Results: The results demonstrated that TGF-β1 could induce SGC-7901 cells EMT and enhance cell invasion. The mRNA and protein level of epithelial marker E-cadherin was downregulated by TGF-β1,whereas the mRNA and protein expression level of Gli-1 and mesenchymal maker protein Vimentin were elevated. Furthermore,TGF-β1 could significantly enhance the invasion ability of SGC-7901 cells,however,co-treated Gli-1 inhibitor GANT 61 with TGF-β1 significantly suppressed TGF-β1 induced EMT and cell invasion. Conclusion: Gli-1 participates in EMT induced by TGF-β1 in gastric cancer cell line SGC-7901.
作者 赵伟锋 陈雪姣 付蕾 胡金龙 卢创新 仓顺东 王朝杰 Zhao Weifeng;Chen Xuejiao;Fu Lei;Hu Jinlong;Lu Chuangxin;Cang Shundong;Wang Chaojie(Department of Medical Oncology,the People's Hospital of Henen Pros#tee,Henan Zhengzhou 450000,China)
出处 《现代肿瘤医学》 CAS 2018年第22期3530-3535,共6页 Journal of Modern Oncology
关键词 胃癌 转化生长因子-β1 核转录因子神经胶质瘤关联癌基因同源物1 上皮间质转化 侵袭 gastric cancer transforming growth factor -β1 ( TGF -β1 ) glioma associated oncogene homolog 1 ( Gli- 1 ) epithelial - mesenchymal transition (EMT) invasion
  • 相关文献

参考文献3

二级参考文献24

  • 1BinLiang,ShanWang,Xue-GuangZhu,Yong-XiangYu,Zhi-RongCui,You-ZhiYu.Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer[J].World Journal of Gastroenterology,2005,11(5):623-628. 被引量:16
  • 2Ferlay Jacques,Shin Hai-Rim,Bray Freddie,Forman David,Mathers Colin,Parkin Donald Maxwell.Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer. Journal international du cancer . 2011
  • 3Wasaburo Koizumi,Hiroyuki Narahara,Takuo Hara,Akinori Takagane,Toshikazu Akiya,Masakazu Takagi,Kosei Miyashita,Takashi Nishizaki,Osamu Kobayashi,Wataru Takiyama,Yasushi Toh,Takashi Nagaie,Seiichi Takagi,Yoshitaka Yamamura,Kimihiko Yanaoka,Hiroyuki Orita,Masahiro Takeuchi.S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial[J]. Lancet Oncology . 2008 (3)
  • 4Peter C. Thuss-Patience,Albrecht Kretzschmar,Dmitry Bichev,Tillman Deist,Axel Hinke,Kirstin Breithaupt,Yasemin Dogan,Bernhard Gebauer,Guido Schumacher,Peter Reichardt.Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer – A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)[J].European Journal of Cancer.2011(15)
  • 5Y.-K. Kang,W.-K. Kang,D.-B. Shin,J. Chen,J. Xiong,J. Wang,M. Lichinitser,Z. Guan,R. Khasanov,L. Zheng,M. Philco-Salas,T. Suarez,J. Santamaria,G. Forster,P. I. McCloud.Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial[].Annals of Oncology.2009
  • 6Bryan J. Dicken,David L. Bigam,Carol Cass,John R. Mackey,Anil A. Joy,Stewart M. Hamilton.Gastric Adenocarcinoma: Review and Considerations for Future Directions[J].Annals of Surgery.2005(1)
  • 7Young Soo Park,Hee Sang Hwang,Hye Jin Park,Min-Hee Ryu,Heung-Moon Chang,Jeong Hwan Yook,Byung Sik Kim,Se Jin Jang,Yoon-Koo Kang.Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?[J].Human Pathology.2012(3)
  • 8Narikazu Boku.HER2-positive gastric cancer[J].Gastric Cancer.2014(1)
  • 9Xiangdong Liu,Robert C. Newton,Peggy A. Scherle.Developing c-MET pathway inhibitors for cancer therapy: progress and challenges[J].Trends in Molecular Medicine.2009(1)
  • 10Kaori Fujimoto-Ouchi,Fumiko Sekiguchi,Hideyuki Yasuno,Yoichiro Moriya,Kazushige Mori,Yutaka Tanaka.Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models[J]. Cancer Chemotherapy and Pharmacology . 2007 (6)

共引文献35

同被引文献14

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部